RPS6KB1 and malignant colon neoplasm: The aim of the current study was to investigate the anticancer activity of InsP6 on colon cancer with focusing on inhibiting the AKT1 kinase and p70S6K1 as mTOR effector, in relation to proliferation and apoptosis of cells.